In Brief: Zeneca Casodex
Executive Summary
Zeneca Casodex: Updated analysis of bicalutamide trial added to support Casodex labeling claim that survival experience for patients with advanced prostate cancer on Casodex-LHRH analogue therapy is no worse than for patients on flutamide-LHRH analogue...